TTIRF yields 500000.00% · JNJ yields 2.13%● Live data
📍 TTIRF pulled ahead of the other in Year 1
Combined, TTIRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TTIRF + JNJ for your $10,000?
Tertiary Minerals plc, together with its subsidiaries, engages in the identification, acquisition, exploration, and development of mineral deposits. The company engages in the development of a multi-commodity project portfolio, including precious metals, base metals, and industrial minerals. It owns interests in the Storuman fluorspar project located in north central Sweden; the Lassedalen fluorspar project located in the south-west of Oslo, Norway; the Pyramid gold project located in the northwest of Reno, Nevada; the Paymaster polymetallic project that includes claims covering an area of 390 acres located in southwest of Tonopah, Nevada; and the Kaaresselkä and Kiekerömaa gold projects located in Finland. The company also holds interests in the Rosendal tantalum project located in south-west Finland; the Lucky copper prospect consisting of 13 claims located in north-east Nevada; and the Mt Tobin prospect comprising claims located to the south of Winnemucca in north central Nevada. Tertiary Minerals plc was incorporated in 1999 and is headquartered in Macclesfield, the United Kingdom.
Full TTIRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.